The Signal, March 2024: Data-fuelled AI insights and GLP-1 drugs
This month’s alternative data insights include vendors’ research on the implementation of AI and deep dives into GLP-1 drug use.
Updates on AI: Data provider insights
Data providers continue to showcase findings that map the changing landscape...